期刊文献+

STAT3、ER、PR在子宫内膜癌中的表达及意义 被引量:7

Expression and significance of STAT3,ER and PR in endometrial carcinoma
下载PDF
导出
摘要 目的:研究STAT3、ER、PR在子宫内膜癌中的表达及意义。方法:采用免疫组织化学方法检测126例子宫内膜癌(Ⅰ型114例,Ⅱ型12例)和50例癌旁组织中STAT3、ER、PR的表达。结果:STAT3、ER、PR在子宫内膜癌中的阳性表达率均显著高于癌旁子宫内膜组织(P<0.05);在子宫内膜癌中STAT3阳性表达率与病理分级、淋巴结转移及病理分型有统计学意义(P<0.05),ER、PR阳性表达率与临床分期、病理分级、淋巴结转移及病理分型有统计学意义(P<0.05)。结论:STAT3与肿瘤的发生、发展、侵袭、转移及预后密切相关,可作为判断预后的指标和浸润的新靶点。ER、PR水平的高低对于评估预后和临床选择内分泌治疗具有指导意义。 Objective:To research the expression and significance of 5TAT3,ER and PR in endolnetrial eareinoma. Methods:Adopt the method of immunohistoehelnistry to test the expression of 5TAT3, ER and PR in 126 cases of endolnetrial eareinolna (114 cases of type Ⅰ ,12 cases of type Ⅱ ) and in 50 cases of adjacent noncancerous tissue. Results:The positive expression rate of 5TAT3, ER and PR in endolnetrial carcinoma was significantly higher than in adjacent endolnetrial tissue (P 〈 0.05). The positive expression rate of 5TAT3 in endolnetrial carcinoma showed statistical significance with pathological grading, lymphatic metastasis and pathological classification ( P 〈 0.05 ). The positive expression rate of ER and PR showed statistical significance with clinical stage, pathological grading,lymphatic metastasis and pathological classification(P 〈 0.05). Conclusion : 5TAT3 is closely related with the happening, development,attack,metastasis and prognosis of tmnor and can be regarded as the index of prognosis judgment and the new target of infihration. The level of ER and PR has guiding significance on the evaluation of prognosis and clinical selecting of endocrine therapy.
出处 《现代肿瘤医学》 CAS 2014年第2期399-402,共4页 Journal of Modern Oncology
关键词 子宫内膜癌 免疫组化 STAT3 ER PR endometrial carcinoma immunohistochemistry STAT3 ER PR
  • 相关文献

参考文献15

  • 1陈乐真.妇产科诊断病理学[M]{H}北京:人民军医出版社,2010204-212.
  • 2祝宇,盛佳雁,徐云泽,吴瑜璇,赵菊平,何竑超,袁菲,芮文斌,张翀宇,计骏,孙福康,周文龙,谢欣,沈周俊,金晓龙.STAT3蛋白、VEGF和MVD在肾上腺皮质癌中的表达及其意义[J].现代泌尿外科杂志,2012,17(4):347-349. 被引量:2
  • 3陆娜娜,尹玉,李昊,江燕,曹立宇.大肠癌中STAT3和VEGF的表达及相关性研究[J].中国组织化学与细胞化学杂志,2012,21(2):122-125. 被引量:5
  • 4汤欣,韩凤娟,隆康健,吴效科.STAT3信号通路在卵巢癌中的研究进展[J].世界中西医结合杂志,2012,7(3):260-262. 被引量:2
  • 5Grandis JR,Drenning SD,Zeng Q. Constitutive activation of STAT3 signaling abrogates.apoptosis in squamous cell carcinogenesis in vivo[J].{H}Proceedings of the National Academy of Sciences(USA),2000,(08):4227-4232.
  • 6Dien J,Amin HM,Chiu N. Signal transducers and activators of metalloproteinase 1 expression and decrease invasivenese of breast cancer[J].{H}AMERICAN JOURNAL OF PATHOLOGY,2006,(02):633-642.
  • 7张国强,曹立宇.STAT3在大肠癌中的表达及其临床意义[J].安徽医药,2012,16(10):1442-1443. 被引量:7
  • 8Horinaga M,Okita H,Nakashima J. Clinical and pathologic significance of activation of signal transducer and activator of transcription 3 in prostate cancer[J].{H}UROLOGY,2005,(03):671-675.
  • 9Eric BH,Zhengz,Song LX. Activated epidermal growth factor receptor stats signaling promotes tumor survival in vivo in non small cell lung cancer[J].{H}Clinical Cancer Research,2005,(23):8288-8294.
  • 10Lassmann S,Schuster I,Walch A. STAT3 mRNA and protein expression in colorectal cancer:effects on STAT3-inducible targets linked to cell survival and proliferation[J].Clin Patol,2007,(02):173-179.

二级参考文献68

  • 1Munechika Enjoji,Makoto Nakamuta,Koji Yamaguchi,Satoshi Ohta,Kazuhiro Kotoh,Marie Fukushima,Masami Kuniyoshi,Tomomi Yamada,Masao Tanaka,Hajime Nawata.Clinical significance of serum levels of vascular endothelial growth factor and its receptor in biliary disease and carcinoma[J].World Journal of Gastroenterology,2005,11(8):1167-1171. 被引量:10
  • 2胡红珍,张轶清,张正荣,孔丽娜,罗永红,张帆.ER、PR和LR在子宫内膜癌中的表达及其意义[J].实用医学杂志,2006,22(2):138-140. 被引量:3
  • 3Bao-He Zhu, Wen-Hua Zhan, Zheng-Rong Li, Zhao Wang, Yu-Long He, Jun-Sheng Peng, Shi-Rong Cai, Jin-Ping Ma, Chang-Hua Zhang, Department of Gastrointestinal & Pancreatic Surgery, First Affiliated Hospital, Sun Yat-Sen University,Gastric Center of Sun Yat-Sen University, Guangzhou 510080, Guangdong Province, China.(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis[J].World Journal of Gastroenterology,2007,13(8):1162-1169. 被引量:30
  • 4李小燕,黄缘.小肠癌分子生物学机制的研究进展[J].中华消化杂志,2007,27(4):286-288. 被引量:4
  • 5Meenakshi S, Zaino RJ, Filiaci V J, et al. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma : a gynecologic oncology group study [ J ] . Gynecol Oncol, 2007, 106 ( 2 ) : 325-333.
  • 6Hoskins WJ, Perez CA, Young RC, et al. Principles and practice of gynecologic oncology [ M ] . Philadelphia : Lippincott Williams and Wilkins, 2000 : 1005-1007.
  • 7Kounelis S, Kapranos N, Kouri E, et al. Immunohistochemical profile of endometrial adenocarcinoma : a study of 61 cases/md review of the literature [ J ] . Mod Pathol, 2000, 13 ( 4 ) : 379-388.
  • 8Gielen SC, Hanekamp EE, Hanifi-moghaddam P, et al. Growth regulation and transcriptional activities of estrogen and progesterone in human endometrial cancer cells [ J ] . Int J Gynecol Cancer, 2006, 16 ( 1 ) : 110-120.
  • 9Ishikawa A, Kudo M, Nakazawa N, et al. Expression of keratinocyte growth factor and its receptor in human endometrial cancer in cooperation with steroid hormones [ J ] . Int J Oncol, 2008.32 ( 3 ) : 565-574.
  • 10Vandenput I, Trovik J, Leunen K, et al. Evolution in endometrial cancer : evidence from an immunohistochemical study [ J ] . Int J Gynecol Cancer, 2011, 21 ( 2 ) : 316-322.

共引文献47

同被引文献50

  • 1张竹青,卢书明,陈美如,李春艳,刘丽娜,吕申.胃癌中STAT3、p-STAT3和Bcl-xL的表达及临床意义[J].肿瘤防治研究,2014,41(5):430-433. 被引量:9
  • 2陈乐真.妇产科诊断病理学[M].北京:人民军医出版社,2010:115-116.
  • 3谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 4Kitchener H, Redman CW, Swart AM, et al. ASTEC-a study in the treatment of endometrial cancer: a randomised tri- al of lymphadenectomy in the treatment of endometrial cancer [J]. Gynecol Oncol, 2006, 101 (Suppll) : $21-$22.
  • 5Cong L, Gasser J, Zhao J, et al. Human adiponectin inhib- its cell growth and induces apoptosis in human endometrial car- cinoma cells, HEC-1A and RL952 [ J]. Endocr Relat Canc- er, 2007, 14 (3):713-720.
  • 6Singh M, Zaino RJ, Filiaci VJ, et al. Relationship of estro- gen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a gynecologic oncology group study [J]. Gynecol Oncol, 2007, 106 (2) : 325-333.
  • 7Catasus L, Gallardo A, Cuatrecasas M, et al. Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis [J ]. Mod Pathol, 2009, 22 (4) : 522-529.
  • 8Hanafi S, Abou- Gabal A, AklS, etal. Value of three di- mensional power Doppler ultrasound in prediction of endometrial carcinoma in patients with postmenopausal bleeding[J]. J Turk Ger Gynecol Assoc, 2014, 15(2) : 78 - 81.
  • 9Showkat MS, Nabi S, Khondker L, et al. Role of transvaginal sonography in the detection of endometrial carcinoma [J]. Bangladesh Med Res Counc Bull, 2013, 39(2) : 80 - 85.
  • 10Gu Z, Ding G, Liang K, et al. TES13N suppresses tumor growth and invasion via manipulating cell cycle progression in endometrial carcinoma[J]. Med Sci Monit, 2014, 14(20) : 980 - 987.

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部